Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
AIDS Research and Human Retroviruses|November 18, 2014
Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIVDarrell H S Tan, Janet M Raboud, Leah Szadkowski, et al.
Immunohorizons|November 24, 2025
Rapid decline of SARS-CoV-2-specific salivary IgA antibody levels in people with hybrid immunity-data from the STOPCoV studySharon L Walmsley, Majid Nabipoor, Gary Chao, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|August 12, 2011
Imaging diagnosis--spinal cord hemangioma in two dogsPhilip Jull, Gemma L Walmsley, Livia Benigni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based RegimensKayode A Balogun, Monica S Guzman Lenis, Eszter Papp, et al.
The Journal of Infectious Diseases|July 7, 2000
Factors contributing to the lack of human immunodeficiency virus type 1 (HIV-1) transmission in HIV-1-discordant partnersD Bienzle, K S MacDonald, F M Smaill, et al.
Antiviral Therapy|October 1, 2004
Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimensMona R Loutfy, Janet M Raboud, Sharon L Walmsley, et al.
AIDS and Behavior|July 21, 2017
Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation AnalysisTaylor McLinden, Erica E M Moodie, Anne-Marie Hamelin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
The Journal of Infectious Diseases|July 18, 2014
HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restrictionEszter Papp, Hakimeh Mohammadi, Mona R Loutfy, et al.
Open Forum Infectious Diseases|July 17, 2025
Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical TrialsSharon L Walmsley, Princy N Kumar, Chloe Orkin, et al.
Pageof 14